Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paromomycin for Cryptosporidiosis in Advanced HIV
NCT00000771Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of paromomycin in cryptosporidiosis, sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
paromomycin
03
Conditions
cryptosporidiosis
Beyond the preview
Go deeper on NCT00000771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000771.